thiazoles has been researched along with tamoxifen in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.45) | 18.7374 |
1990's | 1 (3.45) | 18.2507 |
2000's | 10 (34.48) | 29.6817 |
2010's | 10 (34.48) | 24.3611 |
2020's | 7 (24.14) | 2.80 |
Authors | Studies |
---|---|
Dixon, B; Furr, BJ; Jordan, VC; Prestwich, G | 1 |
Kristofik, MP; Randall, MS; Rehn, T; Selker, RG; Vertosick, FT | 1 |
Beyssen, M; Buxeraud, J; Clédat, D; Jambut, A; Lagorce, J | 1 |
Hermann, R; Jungnickel, S; Lerchl, A; Podhajsky, S | 1 |
Anderson, RE; Cao, W; Elias, RV; Knapp, RR; Li, F; Li, S; McGinnis, JF; Rajala, RV; Yan, X; Yu, X; Zhou, X | 1 |
Barrett, JT; Delk, JN; Gaddy, VT; Kallab, AM; Porter, AG; Schoenlein, PV | 1 |
Grossi, P; Kanter, Rd; Monaci, S; Monshouwer, M; Turlizzi, E; Vignati, L | 1 |
Espinosa, M; Farina, M; Franchi, A; Hermoso, M; Pérez Martínez, S; Rapanelli, M; Ribeiro, ML; Villalón, M | 1 |
Atzeni, S; Azzena, L; Caocci, G; La Nasa, G; Ledda, A; Littera, R; Martorana, L; Orrù, N | 1 |
Chen, S; Lui, K; Mori, T; Tamura, T; Zhou, D | 1 |
Cavalli, A; Gervasio, FL; Masetti, M; Recanatini, M | 1 |
Maslov, AY; Metrikin, M; Vijg, J | 1 |
Chakravarty, D; Challa, R; Cortez, V; Nair, BC; Tekmal, RR; Vadlamudi, RK; Vallabhaneni, S | 1 |
Flomenberg, N; Goldberg, AF; Howell, A; Ko, YH; Lin, Z; Lisanti, MP; Martinez-Outschoorn, UE; Pavlides, S; Pestell, RG; Sotgia, F; Wang, C | 1 |
Corey, SJ; Park, BJ; Whichard, ZL | 1 |
Blair, LJ; Cheng, JQ; Dickey, CA; Gestwicki, JE; Guo, J; Jinwal, UK; Kiray, J; Koren, J; Li, X; Miyata, Y; Nguyen, L; O'Leary, JC | 1 |
Cerbón, MA; Coronel-Cruz, C; González-Sánchez, I; Lira-Rocha, A; Loza-Mejía, MA; Mendoza-Rodríguez, CA; Navarrete, A | 1 |
Ebrahimi Nigjeh, S; Keong, YS; Mohamed Alitheen, NB; Omar, AR; Rasoli, M; Yusoff, FM | 1 |
Lawrence, HR; Lawrence, NJ; Mahajan, K; Mahajan, NP | 1 |
Ann, DK; Chen, YR; Hu, S; Liu, X; Ma, H; Tsou, B; Yen, Y | 1 |
Li, Y; Pan, H; Pan, W; Yang, X; Zhu, Z | 1 |
Chen, IC; Cheng, AL; Hsiao, LP; Huang, IW; Lin, CH; Lu, YS; Wei-Wu Chen, T; Yeh, LC; Yu, HC | 1 |
Chang, YC; Chao, TY; Chen, SC; Chitapanarux, I; Gao, M; Jung, KH; Kim, JH; Lee, KS; Liu, CT; Lu, YS; Park, YH; Shotelersuk, K; Slader, C; Sohn, J; Tseng, LM; Valenti, R; Yang, Y | 1 |
Chen, B; Chen, T; Duan, Y; Han, D; Li, C; Li, Y; Liang, Y; Liu, Y; Song, X; Wang, L; Wang, X; Yang, Q; Zhang, H; Zhang, N; Zhao, W | 1 |
Araklitis, G; Baines, G; Cardozo, L; da Silva, AS; Robinson, D | 1 |
Clark, AS; DeMichele, A; Makhlin, I | 1 |
Eisner, JR; Lerner, LM; Michmerhuizen, AR; Pesch, AM; Pierce, LJ; Rae, JM; Schwartz, R; Speers, CW; Ward, C; Wilder-Romans, K; Zhang, A | 1 |
Fan, X; Jiang, Z; Li, M; Lu, Q; Yu, Q; Zhang, L; Zhao, W; Zhu, Y | 1 |
Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
2 review(s) available for thiazoles and tamoxifen
Article | Year |
---|---|
Recent advances in managing overactive bladder.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Botulinum Toxins; Denervation; Drug Implants; Humans; Laser Therapy; Pyrimidinones; Pyrrolidines; Tamoxifen; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive | 2020 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
27 other study(ies) available for thiazoles and tamoxifen
Article | Year |
---|---|
The mode of action of the antitumour agent GP 48,989 in the rat.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Castration; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Ovary; Random Allocation; Rats; Receptors, Estrogen; Tamoxifen; Thiazoles; Time Factors; Transplantation, Homologous; Uterus | 1979 |
A comparison of the relative chemosensitivity of human gliomas to tamoxifen and n-desmethyltamoxifen in vitro.
Topics: Colorimetry; Coloring Agents; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioma; Humans; Tamoxifen; Tetrazolium Salts; Thiazoles; Thymidine; Tumor Cells, Cultured | 1994 |
Antithyroid action of tamoxifen in the rat: in vivo and in vitro studies.
Topics: Animals; Antithyroid Agents; Estrogen Receptor Modulators; Female; Iodine; Models, Molecular; Molecular Conformation; Rats; Rats, Wistar; Tamoxifen; Thiazoles; Thiazolidines; Thyroid Gland; Thyroid Hormones | 2000 |
Potentiation of antiproliferative effects of tamoxifen and ethanol on mouse hepatoma cells by melatonin: possible involvement of mitogen-activated protein kinase and induction of apoptosis.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Cell Survival; Coloring Agents; Dose-Response Relationship, Drug; Drug Synergism; Ethanol; Liver Neoplasms; Melatonin; Mice; Mitogen-Activated Protein Kinase Kinases; Molecular Biology; Phosphorylation; Tamoxifen; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |
Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection.
Topics: Animals; Apoptosis; Blotting, Western; Calcium-Binding Proteins; Cells, Cultured; Chromones; Coloring Agents; DNA Fragmentation; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Electroretinography; Enzyme Inhibitors; Estradiol; Eye Proteins; Glutathione Transferase; Hippocalcin; Hydrogen Peroxide; Immunohistochemistry; In Situ Nick-End Labeling; Insulin; Light; Lipoproteins; Morpholines; Nerve Tissue Proteins; Neurons; Phosphatidylinositol 3-Kinases; Phosphorylation; Progesterone; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Recoverin; Retina; Signal Transduction; src Homology Domains; Tamoxifen; Tetrazolium Salts; Thiazoles | 2004 |
Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Proliferation; Coloring Agents; DNA Fragmentation; Drug Resistance, Neoplasm; Enzyme Activation; Estradiol; Estrogen Receptor Modulators; Fulvestrant; G1 Phase; Hormone Antagonists; Humans; Immunoblotting; Mifepristone; Phosphorylation; Receptors, Estrogen; Receptors, Progesterone; Resting Phase, Cell Cycle; Tamoxifen; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics.
Topics: Adenosine Triphosphate; Albendazole; Amitriptyline; Animals; Buthionine Sulfoximine; Carbamazepine; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Chromans; Coculture Techniques; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dapsone; Enzyme Activation; Flutamide; Glutathione; Humans; Isoniazid; Microsomes; Ochratoxins; Piperazines; Quinidine; Substrate Specificity; Tamoxifen; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Toxicity Tests; Triazolam; Troglitazone; Xenobiotics | 2005 |
17-beta-Estradiol upregulates COX-2 in the rat oviduct.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Epithelium; Estradiol; Estrous Cycle; Female; Immunohistochemistry; Meloxicam; Membrane Proteins; Nitrobenzenes; Oviducts; Pregnancy; Progesterone; Prostaglandins; Rats; Rats, Wistar; Receptors, Estradiol; Sulfonamides; Tamoxifen; Thiazines; Thiazoles; Up-Regulation | 2006 |
Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia.
Topics: Aged; Dasatinib; Gynecomastia; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Protein Kinase Inhibitors; Pyrimidines; Selective Estrogen Receptor Modulators; Tamoxifen; Thiazoles; Treatment Outcome | 2008 |
MCF-7aro/ERE, a novel cell line for rapid screening of aromatase inhibitors, ERalpha ligands and ERRalpha ligands.
Topics: Anastrozole; Aromatase Inhibitors; Biological Assay; Cell Line, Tumor; Coumarins; ERRalpha Estrogen-Related Receptor; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Fulvestrant; Genes, Reporter; Genistein; Humans; Letrozole; Ligands; Luciferases; Nitriles; Receptors, Estrogen; Response Elements; Tamoxifen; Thiazoles; Transfection; Triazoles | 2008 |
Exploring complex protein-ligand recognition mechanisms with coarse metadynamics.
Topics: Binding Sites; Computer Simulation; Crystallography, X-Ray; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Escherichia coli; Estrogen Receptor alpha; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Ligands; Models, Chemical; Models, Molecular; Molecular Structure; Tamoxifen; Thermodynamics; Thiazoles; Triclosan; Urea | 2009 |
A dual-activation, adenoviral-based system for the controlled induction of DNA double-strand breaks by the restriction endonuclease SacI.
Topics: Adenoviridae; Animals; Anti-Bacterial Agents; Cell Culture Techniques; Cell Survival; Cells, Cultured; Coloring Agents; Comet Assay; Deoxyribonucleases, Type II Site-Specific; DNA; DNA Breaks, Double-Stranded; DNA Damage; Dose-Response Relationship, Drug; Doxycycline; Embryo, Mammalian; Enzyme Activation; Fibroblasts; Fluorescent Antibody Technique, Direct; Genetic Vectors; Immunohistochemistry; Mice; Mice, Inbred C57BL; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Transgenes | 2009 |
Significance of ER-Src axis in hormonal therapy resistance.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Co-Repressor Proteins; Dasatinib; Drug Resistance, Neoplasm; Drug Synergism; Estrogen Receptor alpha; Female; Gene Knockdown Techniques; Humans; Letrozole; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Nitriles; Phosphorylation; Pyrimidines; Receptor, ErbB-2; RNA Interference; src-Family Kinases; Tamoxifen; Thiazoles; Transcription Factors; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Line; Coculture Techniques; Dasatinib; Drug Resistance, Neoplasm; Female; Fibroblasts; Glycolysis; Humans; Pyrimidines; Tamoxifen; Telomerase; Thiazoles | 2011 |
Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Breast Neoplasms; Butadienes; Cell Line, Tumor; Chromones; Dasatinib; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Epothilones; Female; Humans; Morpholines; Niacinamide; Nitriles; Paclitaxel; Phenylurea Compounds; Pyridines; Pyrimidines; Signal Transduction; Sirolimus; Sorafenib; Tamoxifen; Thiazoles | 2012 |
Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance.
Topics: Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Estrogen Receptor alpha; HEK293 Cells; HeLa Cells; Humans; Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridinium Compounds; Tamoxifen; Thiazoles | 2012 |
Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Cell Survival; Cisplatin; DNA Fragmentation; Drug Screening Assays, Antitumor; Drug Synergism; Female; HeLa Cells; Humans; Imatinib Mesylate; K562 Cells; MCF-7 Cells; Piperazines; Pyrimidines; Tamoxifen; Thiazoles; Uterine Cervical Neoplasms | 2012 |
Cytotoxic effect of ethanol extract of microalga, Chaetoceros calcitrans, and its mechanisms in inducing apoptosis in human breast cancer cell line.
Topics: Annexin A5; Apoptosis; Biological Products; Breast Neoplasms; Cell Cycle; Cell Proliferation; Ethanol; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; MCF-7 Cells; Microalgae; Propidium; Regression Analysis; Tamoxifen; Tetrazolium Salts; Thiazoles | 2013 |
ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Amino Acid Sequence; Animals; Binding Sites; Cell Line, Tumor; Dasatinib; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Jumonji Domain-Containing Histone Demethylases; Luciferases; Mammary Glands, Human; Methylation; Models, Molecular; Molecular Sequence Data; Neuregulin-1; Protein Binding; Protein-Tyrosine Kinases; Pyrimidines; Receptor, ErbB-2; Signal Transduction; Tamoxifen; Thiazoles; Transcription, Genetic | 2014 |
Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells.
Topics: Animals; Antimalarials; Antineoplastic Agents, Hormonal; Apoptosis; Autophagy; Benzamides; Blotting, Western; Breast Neoplasms; Cell Proliferation; Chloroquine; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleoside Diphosphate Reductase; RNA, Messenger; Tamoxifen; Thiazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
The reversion of anti-cancer drug antagonism of tamoxifen and docetaxel by the hyaluronic acid-decorated polymeric nanoparticles.
Topics: A549 Cells; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coumarins; Docetaxel; Female; Humans; Hyaluronic Acid; Male; MCF-7 Cells; Mice; Nanoparticles; Polymers; Tamoxifen; Taxoids; Thiazoles | 2017 |
Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen.
Topics: Aminopyridines; Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Estrogen Receptor alpha; Female; Humans; Morpholines; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Signal Transduction; Tamoxifen; Thiazoles | 2017 |
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclin-Dependent Kinase 4; Female; Goserelin; Humans; Morpholines; Phosphatidylinositol 3-Kinases; Receptor, ErbB-2; Tamoxifen; Thiazoles | 2021 |
Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Pyridines; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Thiazoles | 2020 |
Setting the Pick: Can PI3K Inhibitors Circumvent CDK4/6 Inhibitor Resistance?
Topics: Aminopyridines; Breast Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Goserelin; Humans; Morpholines; Phosphatidylinositol 3-Kinases; Tamoxifen; Thiazoles | 2021 |
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer.
Topics: Androgen Receptor Antagonists; Androgens; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Naphthalenes; Piperidines; Pyrrolidines; Radiation Tolerance; Receptors, Androgen; Receptors, Estrogen; Tamoxifen; Thiazoles; Triazoles | 2022 |
Fatostatin inhibits SREBP2-mediated cholesterol uptake via LDLR against selective estrogen receptor α modulator-induced hepatic lipid accumulation.
Topics: Breast Neoplasms; Cholesterol; Estrogen Receptor alpha; Female; Humans; Liver; Non-alcoholic Fatty Liver Disease; Pyridines; Receptors, LDL; Selective Estrogen Receptor Modulators; Sterol Regulatory Element Binding Protein 2; Tamoxifen; Thiazoles | 2022 |